Medical Services

Chronic Lymphocytic Leukemia (CLL) is a slow-growing type of blood cancer that originates in the bone marrow and affects lymphocytes, a vital part of the immune system. Unlike acute leukemias, CLL progresses gradually, often remaining undetected in its early stages. Many patients are diagnosed incidentally during routine blood tests showing high white blood cell counts.

Symptoms may include fatigue, swollen lymph nodes, frequent infections, night sweats, weight loss, and an enlarged spleen. However, some patients remain asymptomatic for years. Risk factors include age (commonly affecting individuals over 60), family history of blood cancers, and genetic mutations.

Diagnosis typically involves blood tests, flow cytometry, and bone marrow biopsy. The treatment approach depends on disease stage and patient health. Early-stage cases may require only "watchful waiting," while advanced stages could involve targeted therapies, chemotherapy, immunotherapy, or stem cell transplantation.

Although CLL is generally considered incurable, modern therapies significantly improve survival rates and quality of life. With continuous medical advancements, patients with CLL are living longer, healthier lives. Early detection, regular monitoring, and personalized treatment strategies remain essential for effective management of this chronic blood cancer.